c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
TG Therapeutics targets $1B 2026 global revenue as it plans mid-2027 simplified IV dosing and 2028 subcu launch
Seeking Alpha | Nov 9, 2026 5:02 PM EST
Read original article